1. Berruti A, Baudin E, Gelderblom H et al. Adrenal cancer: ESMO (European Society for Medical Oncology) Clinical Practice Guidelines for diagnosis, treatment and follow-up on behalf of the ESMO Guidelines Working Group. Annals of Oncology. 2012;23:131-138.
2. NCCN Clinical Practice Guidelines in Oncology, Neuroendocrine tumor, Version 1.2014.
3. Schteingart DE, Doherty GM, Gauger PG et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12:667.
4. Langer P, Cupisti K, Bartsch DK et al. Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg. 2002;26:891-896.
5. Gicquel C, Le Bouc Y. Molecular markers for malignancy in adrenocortical tumors. Horm Res. 1997;47:269-272.
6. Бельцевич ДГ, Кузнецов НС, Солдатова ТВ, Ванушко ВЭ. Инциденталома надпочечников. Эндокринная хирургия. 2009. №1.
7. Funder JW (https://www.ncbi.nlm.nih.gov/pubmed/? term=Funder%20JW%5BAuthor%5D&cauthor=true&cauthor_uid=18552288), Carey RM (https://www.ncbi.nlm.nih.gov/pubmed/? term=Carey%20RM%5BAuthor%5D&cauthor=true&cauthor_uid=18552288) et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. (https://www.ncbi.nlm.nih.gov/pubmed/18552288) 2008; 93(9):3266-81.
8. Guignat L (https://www.ncbi.nlm.nih.gov/pubmed/? term=Guignat%20L%5BAuthor%5D&cauthor=true&cauthor_uid=20375177), Bertherat J (https://www.ncbi.nlm.nih.gov/pubmed/? term=Bertherat%20J%5BAuthor%5D&cauthor=true&cauthor_uid=20375177). The diagnosis of Cushing"s syndrome: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. Eur J Endocrinol. (https://www.ncbi.nlm.nih.gov/pubmed/20375177) 2010;163(1):9-13.
9. Lenders JW (https://www.ncbi.nlm.nih.gov/pubmed/? term=Lenders%20JW%5BAuthor%5D&cauthor=true&cauthor_uid=24893135), Duh QY (https://www.ncbi.nlm.nih.gov/pubmed/? term=Duh%20QY%5BAuthor%5D&cauthor=true&cauthor_uid=24893135), Eisenhofer G (https://www.ncbi.nlm.nih.gov/pubmed/? term=Eisenhofer%20G%5BAuthor%5D&cauthor=true&cauthor_uid=24893135) et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.uJ Clin Endocrinol Metab. (https://www.ncbi.nlm.nih.gov/pubmed/24893135) 2014;99(6):1915-42.
10. Libe R, Dall’Asta C, Barbetta L et al. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol. 2002;147:489-494.
11. Terzolo M, Reimondo G, Bovio S, Angeli A Subclinical Cushing’s syndrome. Pituitary. 2004;7:217-223.
10. Kirkby-Bott J, Brunaud L, Mathonet M, Hamoir E, Kraimps JL, Tresallet C, Amar L, Rault A, Henry JF, Carnaille B. Ectopic hormone-secreting pheochromocytoma: a francophone observational study. World J Surg. 2012;36(6):1382-1388.
11. Li XG, Zhang DX, Li X. et al. Adrenocorticotropic hormone-producing pheochromocytoma: a case report and review of the literature. Chin Med J (Engl). 2012;125(6):1193-1196.
12. Cohade C, Broussaud S, Louiset E, Bennet A, Huyghe E, Caron P. Ectopic Cushing"s syndrome due to a pheochromocytoma: a new case in the postpartum and review of literature. Gynecol Endocrinol. 2009;25(9):624-627.
13. Gardet V et al. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma. J Hypertens. 2001;19:1029-1035.
14. Nieman LK, Biller BMK, Findling JW et al. The diagnosis of Cushing’s syndrome:an endocrine society clinical practice guideline Journal of Clin Endoc & Met. 2008;93(5):1526-1540.
15. Newell-Price J, Trainer P, Besser M, Grossman A The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing"s states. Endocr Rev 1998;19:647-672.
16. Pecori Giraldi F, Ambrogio AG, De Martin Met al. Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J Clin Endocrinol Metab. 2007;92:4123-4129.
17. Tsagarakis S, Vassiliadi D, Thalassinos N. Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest. 2006;29:471-482.
18. Mitchell IC, Auchus RJ, Juneja K et al. “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 2007;142:900-905.
19. Mitchell IC, Auchus RJ, Juneja K et al. “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 2007;142:900-905.
20. Reincke M Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am. 2000;29:43-56.
21. Pacak K Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 2007;92:4069-4079.
22. Williams DT, Dann S, Wheeler MH. Phaeochromocytoma - views on current management. Eur J Surg Oncol. 2003;29:483-490.
23. Young W.F.,Jr. The Incidentally Discovered Adrenal Mass. N Engl J Med. 2007;356:601-10.
24. An Endocrine Society Clinical Practice Guidelines. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism. J Clin Endocrinol Metab. 2008;93(9):3266-3281.
25. Трошина ЕА, Бельцевич ДГ, Молашенко НВ. Диагностика и дифференциальная диагностика первичного гиперальдостеронизма. Клиническая медицина. 2009;5:15-20.
26. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85(2):637-644. (http://www.ncbi.nlm.nih.gov/pubmed/10690869)
27. Angeli A, Osella G, Ali A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res. 1997;47:279-283. (http://www.ncbi.nlm.nih.gov/pubmed/10690869)
28. Chang A, (https://www.ncbi.nlm.nih.gov/pubmed/? term=Chang%20A%5BAuthor%5D&cauthor=true&cauthor_uid=3823423)Glazer HS. Adrenal gland: MR imaging. (https://www.ncbi.nlm.nih.gov/pubmed/? term=Glazer%20HS%5BAuthor%5D&cauthor=true&cauthor_uid=3823423)Radiology. 1987;163(1):123-8. (https://www.ncbi.nlm.nih.gov/pubmed/3823423)